Evidence map›Paper›PMID 35422696›Full record

ArticleFrontiers in aging neuroscience2022

Association Between Copper and Global Cognition and the Moderating Effect of Iron.

Young Min Choe, Guk-Hee Suh, Boung Chul Lee, Ihn-Geun Choi, Jun Ho Lee, Hyun Soo Kim, Jee Wook Kim

Open access · goldAbstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Young Min ChoeDepartment of Neuropsychiatry, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, South Korea.
Guk-Hee SuhDepartment of Neuropsychiatry, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, South Korea.
Boung Chul LeeDepartment of Psychiatry, Hallym University College of Medicine, Chuncheon, South Korea.
Ihn-Geun ChoiDepartment of Psychiatry, Hallym University College of Medicine, Chuncheon, South Korea.
Jun Ho LeeDepartment of Neuropsychiatry, Seoul National University Hospital, Seoul, South Korea.
Hyun Soo KimDepartment of Laboratory Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, South Korea.
Jee Wook KimDepartment of Neuropsychiatry, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, South Korea.
Hallym University · KRHallym University Dongtan Sacred Heart Hospital · KRSeoul National University Hospital · KRThe Seoul Institute · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Despite the known association between abnormal serum copper levels and Alzheimer's disease (AD) or cognitive decline, the association between copper, iron, and cognition remains poorly investigated. We examined the association between serum copper levels and global cognition measured using the Mini-Mental State Examination (MMSE) in older adults with normal copper levels. We also explored the moderating effect of iron on this association. Methods: The study enrolled 99 non-demented adults between 65 and 90 years of age. All the participants underwent comprehensive clinical assessments and serum copper measurements. Global cognitive performance was measured by the MMSE. All copper levels were within the normal range and were stratified into three categories: < 87 (low), 87-98 (medium), and > 98 (high: used as a reference category) μg/dL. Results: Serum copper level (as a continuous variable) was significantly associated with MMSE score ( Conclusion: Our findings from non-demented older adults suggest that a low serum copper level within the normal range was associated with AD or cognitive decline and this is moderated by iron. To prevent AD or cognitive decline, clinicians need to pay attention to avoiding low serum copper and iron levels, even within the clinical normal range.

Indexed as

Alzheimer’s diseasecopperglobal cognitionironMMSE

Identifiers

PMID35422696
PMCPMC9003994
OpenAlexW4220856453

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.